Healthcare, Section 5: What Could Improve Relatively Quickly — Research
Many near-term healthcare improvements do not require new scientific breakthroughs. They require delivering proven capabilities more reliably.
Section 5 — What Could Improve Relatively Quickly
Join the conversation about The Equality Project on Reddit →
Section Thesis
Many near-term healthcare improvements do not require new scientific breakthroughs. They require delivering proven capabilities more reliably: expanding access to existing care, strengthening prevention, reducing unnecessary friction, extending healthcare workers’ capacity, and using technology to support better delivery.
These changes cannot solve every healthcare challenge. Workforce training, infrastructure, trust, difficult diseases, implementation complexity, and resource limits remain real constraints. But meaningful improvements could reduce substantial suffering within years rather than generations because many of the required capabilities already exist.
Section Argument Map
5.1 — Expand Access To What Already Works
Argument: The fastest healthcare gains often come from broader access to interventions that already exist. Hypertension treatment, diabetes management, cancer screening, vaccination, mental-health treatment, maternal care, and essential medicines show that the bottleneck is often not knowledge but diagnosis, affordability, adherence support, follow-up, and consistent delivery.
5.2 — Shift Upstream Toward Prevention
Argument: Preventing suffering is often easier, cheaper, and more humane than repairing damage after it occurs. Prevention cannot replace treatment, but earlier intervention can reduce disease progression, complications, disability, premature death, and higher-cost care later.
5.3 — Reduce Friction In Care Delivery
Argument: Many healthcare improvements do not require discovering new treatments; they require helping existing systems function better. Administrative complexity, disconnected information systems, insurance processes, scheduling barriers, unnecessary delays, and documentation burden reduce the effectiveness of existing medical capability.
5.4 — Extend Human Capacity
Argument: Healthcare remains fundamentally constrained by people. Capacity can expand through better teams, better workflows, community-based care, telehealth, AI-supported administration, and appropriate distribution of tasks, but technology does not replace the need for human care.
5.5 — End With Realism
Argument: Near-term improvement is possible, but immediate perfection is not. Some improvements may happen within one to three years; others require medium-term system-building; deeper workforce, infrastructure, public-health, rural-care, and social-determinants work belongs to the longer horizon.
Research Notes
5.1 — Expand Access To What Already Works
Core Claim
The fastest way to benefit from medical progress is making sure people can actually receive capabilities humanity has already created. Many major health opportunities depend less on future discovery than on diagnosis, access, affordability, adherence support, follow-up, and consistent delivery.
Evidence
Source: CDC/NCHS, “Hypertension Prevalence, Treatment, and Control Among Adults: United States, August 2021–August 2023” / Data Brief No. 511
URL: https://www.cdc.gov/nchs/products/databriefs/db511.htm
Date / Data period: August 2021–August 2023; Data Brief No. 511
Finding: CDC/NCHS reports that hypertension affected approximately 47.7% of U.S. adults during August 2021–August 2023. Prevalence increased dramatically with age: 23.4% among adults ages 18–39, 52.5% among adults ages 40–59, and 71.6% among adults age 60 and older.
Role in argument: Establishes hypertension as a large-scale, measurable, common health condition where near-term gains depend heavily on detection, monitoring, treatment access, medication adherence, and follow-up.
Caveats / limits: This source establishes prevalence and age distribution. It does not by itself prove which delivery interventions are most effective or sufficient to control hypertension.
Source: Million Hearts / HHS, “Estimated Hypertension Prevalence, Treatment, and Control Among U.S. Adults”
URL: https://millionhearts.hhs.gov/data-reports/hypertension-prevalence.html
Date / Data period: TBD
Finding: Million Hearts estimates that nearly half of U.S. adults have hypertension, approximately 119.9 million people, and that only about 1 in 4 adults with hypertension have it controlled.
Role in argument: Shows the gap between a measurable, monitorable, treatable condition and actual control. This makes hypertension one of the clearest examples of a delivery problem rather than a medical mystery.
Caveats / limits: This source supports the scale of the hypertension-control gap, but it does not prove that any single intervention can close the gap.
Source: CDC, “Diabetes Self-Management Education and Support”
URL: https://www.cdc.gov/diabetes/education-support-programs/index.html
Date / Data period: TBD
Finding: CDC describes Diabetes Self-Management Education and Support as an evidence-based service that helps people manage diabetes. CDC reports DSMES is associated with improved blood sugar control, fewer complications, healthier behaviors, improved quality of life, and reduced healthcare costs.
Role in argument: Shows that diabetes management includes proven support systems, not only medication or individual willpower. It demonstrates that existing interventions can reduce suffering when people can access them.
Caveats / limits: DSMES effectiveness depends on access, referral, participation, affordability, cultural fit, continuity, and broader clinical support.
Source: American Diabetes Association, “Standards of Care in Diabetes”
URL: https://diabetesjournals.org/care/issue
Date / Data period: TBD
Finding: American Diabetes Association standards emphasize that diabetes management requires access to appropriate medication, glucose monitoring, lifestyle support, and ongoing clinical care.
Role in argument: Supports the claim that diabetes is manageable through an ongoing system of tools and care rather than a one-time intervention.
Caveats / limits: The URL points to the Standards of Care issue page rather than a specific guideline chapter. Final publication may need the exact annual Standards article or chapter if using a specific recommendation.
Source: National Cancer Institute, “Cancer Screening Overview”
URL: https://www.cancer.gov/about-cancer/screening
Date / Data period: TBD
Finding: National Cancer Institute explains that cancer screening can reduce mortality by detecting certain cancers earlier, when treatment may be more effective.
Role in argument: Connects near-term improvement to existing detection systems. Screening shows that some deaths can be reduced when known tools reach people consistently.
Caveats / limits: Screening benefits vary by cancer type, risk profile, screening test, age, follow-up capacity, false positives, overdiagnosis, and access to treatment.
Source: USPSTF, “Colorectal Cancer Screening”
URL: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
Date / Data period: TBD
Finding: USPSTF recommends colorectal cancer screening for adults ages 45–75.
Role in argument: Provides a concrete example of an existing evidence-based screening recommendation where improved uptake could reduce suffering and mortality.
Caveats / limits: Screening recommendation does not guarantee access, affordability, follow-up colonoscopy capacity, timely treatment, or equitable uptake.
Source: USPSTF, “Breast Cancer Screening”
URL: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
Date / Data period: TBD
Finding: USPSTF recommends breast cancer screening every other year for women ages 40–74.
Role in argument: Provides another concrete example of an existing evidence-based screening recommendation.
Caveats / limits: Screening benefits and harms vary by age, risk, test quality, follow-up, overdiagnosis, false positives, and access to treatment.
Source: CDC Preventing Chronic Disease, “Cancer Screening Use”
URL: https://www.cdc.gov/pcd/issues/2025/25_0139.htm
Date / Data period: 2025
Finding: CDC reports that screening rates remain uneven, with some recommended cancer screenings declining.
Role in argument: Shows that even when screening recommendations exist, delivery remains incomplete and uneven.
Caveats / limits: The source supports uneven screening uptake, but the section may need more precise screening-type details if used for detailed claims.
Source: CDC MMWR / Childhood Vaccination Coverage
URL: https://www.cdc.gov/mmwr/
Date / Data period: TBD
Finding: CDC reports many childhood vaccination rates remain high but gaps persist. Recent childhood coverage includes polio vaccine above 90%, Hepatitis B above 90%, MMR about 90%, with other vaccines having lower uptake.
Role in argument: Shows that vaccination is both a major success and an ongoing delivery task. Maintaining high coverage is part of near-term preventable-suffering reduction.
Caveats / limits: The URL is a broad MMWR page rather than a specific report. Final publication should use the exact CDC childhood vaccination coverage report if the precise percentages remain load-bearing.
Source: CDC SchoolVaxView
URL: https://www.cdc.gov/schoolvaxview/data/index.html
Date / Data period: TBD
Finding: CDC school vaccination monitoring shows exemption rates have increased in recent years.
Role in argument: Supports the claim that vaccination success is fragile and depends on maintaining delivery systems, school requirements, access, and public trust.
Caveats / limits: Exemption trends do not by themselves explain causes, local variation, or outbreak risk.
Source: National Institute of Mental Health, “Mental Illness” statistics
URL: https://www.nimh.nih.gov/health/statistics/mental-illness
Date / Data period: TBD
Finding: NIMH reports that tens of millions of U.S. adults experience mental illness annually and that significant gaps remain between need and treatment.
Role in argument: Supports mental healthcare as a near-term access opportunity: interventions exist, but systems do not reliably reach everyone who needs them.
Caveats / limits: Mental illness categories, severity, treatment need, treatment type, and adequacy of treatment vary; this source should not be used to imply that all mental-health needs can be met quickly.
Source: SAMHSA, “National Survey on Drug Use and Health”
URL: https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health
Date / Data period: TBD
Finding: SAMHSA’s National Survey on Drug Use and Health documents continuing behavioral-health treatment gaps.
Role in argument: Reinforces the claim that mental healthcare illustrates the gap between having interventions and having accessible systems capable of delivering those interventions.
Caveats / limits: The URL is a survey-program page rather than a specific annual NSDUH report. Final publication may need the exact year and table if using specific statistics.
Synthesis
The evidence supports the claim that meaningful near-term improvement can come from broader access to existing tools. Hypertension control, diabetes management, cancer screening, vaccination, and mental-health treatment all show the same pattern: medical and public-health capabilities exist, but impact depends on detection, access, affordability, adherence support, follow-up, continuity, and delivery systems. The section’s strongest claim is not that these conditions are easy to solve, but that many gains do not require discovering entirely new medical capabilities.
5.2 — Shift Upstream Toward Prevention
Core Claim
Preventing suffering is often easier, cheaper, and more humane than repairing damage after it occurs. Prevention cannot replace treatment, but earlier intervention can reduce disease progression, complications, disability, premature death, and higher-cost treatment later.
Evidence
Source: CDC Preventing Chronic Disease
URL: https://www.cdc.gov/pcd/issues/2024/23_0267.htm
Date / Data period: 2024
Finding: CDC reports that chronic diseases are the leading causes of illness, disability, and death in the United States and that chronic diseases and mental-health conditions account for approximately 90% of annual healthcare spending.
Role in argument: Establishes why prevention matters: chronic conditions dominate modern health burden and spending.
Caveats / limits: This does not prove all chronic disease is preventable or that prevention can eliminate the need for treatment.
Source: CDC, “Health and Economic Benefits of High Blood Pressure Interventions”
URL: https://www.cdc.gov/nccdphp/priorities/high-blood-pressure.html
Date / Data period: TBD
Finding: CDC reports that self-measured blood pressure monitoring combined with clinical support could produce an estimated return of $7.50–$19.34 per $1 spent over 10 years compared with standard treatment.
Role in argument: Provides a concrete example of a prevention and management intervention that could improve health and produce economic returns.
Caveats / limits: The finding is an estimate. Real-world results depend on implementation, patient participation, clinical support, device access, follow-up, and payment systems.
Source: Community Preventive Services Task Force / Community Guide, “Team-Based Care to Improve Blood Pressure Control”
URL: https://www.thecommunityguide.org/findings/heart-disease-stroke-prevention-team-based-care-improve-blood-pressure-control.html
Date / Data period: TBD
Finding: The Community Preventive Services Task Force recommends team-based care for improving blood-pressure control. Evidence shows team-based care increases controlled blood pressure and reduces systolic and diastolic blood pressure.
Role in argument: Shows that prevention and chronic-disease management can improve through system design, not only individual behavior.
Caveats / limits: Team-based care requires staffing, workflows, training, payment support, coordination, and patient engagement.
Source: National DPP Coverage Toolkit, “Evidence”
URL: https://coveragetoolkit.org/about-national-dpp/evidence/
Date / Data period: TBD
Finding: The National Diabetes Prevention Program is based on research showing lifestyle intervention reduced diabetes incidence by 58% among participants.
Role in argument: Provides a clear example of an existing prevention intervention that can reduce progression to disease.
Caveats / limits: Program effectiveness depends on recruitment, retention, coverage, accessibility, cultural fit, and long-term support. Trial or program outcomes may not automatically generalize across all populations or delivery settings.
Source: CDC Preventing Chronic Disease
URL: https://www.cdc.gov/pcd/issues/2025/24_0501.htm
Date / Data period: 2025
Finding: CDC identifies scalable interventions addressing modifiable risk factors including diet, obesity, and physical inactivity.
Role in argument: Supports the claim that prevention is not vague wellness language; specific scalable interventions exist.
Caveats / limits: Modifiable risk factors are shaped by structural conditions. Prevention should not be framed as individual responsibility alone.
Synthesis
The evidence supports shifting upstream toward prevention while preserving treatment as essential. Chronic disease dominates illness, disability, death, and spending. Blood-pressure monitoring with clinical support, team-based hypertension care, diabetes prevention, and scalable interventions addressing diet, obesity, and physical inactivity all show that prevention can reduce future suffering. The caveat is that prevention requires systems: early identification, access, clinical support, payment, trust, and conditions that make healthier choices possible.
5.3 — Reduce Friction In Care Delivery
Core Claim
Many healthcare improvements do not require discovering new treatments. They require helping existing systems function better by reducing unnecessary administrative complexity, disconnected information systems, insurance-process delays, scheduling barriers, documentation burden, and friction that consumes patient and clinician capacity.
Evidence
Source: Commonwealth Fund, “High U.S. Health Care Spending: Where Is It All Going?”
URL: https://www.commonwealthfund.org/publications/issue-briefs/2023/oct/high-us-health-care-spending-where-is-it-all-going
Date / Data period: 2023
Finding: Commonwealth Fund identifies administrative costs as a major contributor to high U.S. healthcare spending. Research cited by Commonwealth Fund estimates approximately $250 billion in hospital administrative costs and $205 billion in clinical-services administrative costs.
Role in argument: Establishes that administrative simplification represents a major opportunity because large resources are currently devoted to navigating complexity.
Caveats / limits: Not all administration is waste. Some administration supports safety, coordination, payment, accountability, quality tracking, and compliance.
Source: American Medical Association, “Prior Authorization Physician Survey”
URL: https://www.ama-assn.org/system/files/prior-authorization-survey.pdf
Date / Data period: 2024 physician survey
Finding: AMA’s 2024 physician survey found that 94% of physicians reported prior authorization delays access to necessary care; 93% reported prior authorization has a negative impact on patient outcomes; 24% reported prior authorization contributed to a serious adverse event; and 87% reported prior authorization increases overall healthcare resource use.
Role in argument: Supports the claim that poorly designed administrative systems can create delays, increase clinician burden, and prevent patients from receiving appropriate care.
Caveats / limits: This is a physician survey by a professional association. It reflects physician-reported experience and should be used carefully. Prior authorization exists partly to prevent unnecessary care, manage costs, and encourage evidence-based practice.
Source: American Hospital Association, “AMA survey shows physicians, patients heavily burdened by prior authorization”
URL: https://www.aha.org/news/headline/2024-06-20-ama-survey-shows-physicians-patients-heavily-burdened-prior-authorization
Date / Data period: 2024
Finding: American Hospital Association summarizes AMA survey findings showing physicians and patients are heavily burdened by prior authorization.
Role in argument: Provides an additional institutional summary of the prior-authorization burden.
Caveats / limits: AHA is a hospital industry organization and is summarizing AMA survey findings; it should not replace the primary AMA source.
Source: CMS, “Interoperability and Prior Authorization Final Rule”
URL: https://www.cms.gov/priorities/burden-reduction/overview/interoperability/policies-regulations/cms-interoperability-prior-authorization-final-rule-cms-0057-f
Date / Data period: Final rule issued 2024
Finding: CMS finalized the Interoperability and Prior Authorization Final Rule in 2024. The rule aims to improve electronic exchange of health information, streamline prior authorization, increase transparency, and reduce administrative burden across affected programs including Medicare Advantage, Medicaid, CHIP, and federally facilitated exchange plans.
Role in argument: Provides a concrete example that administrative improvement is not imaginary: systems can be redesigned, information flows can improve, and administrative processes can be simplified.
Caveats / limits: Implementation matters. A rule does not automatically produce a functioning system.
Source: CMS, “CMS Interoperability and Prior Authorization Final Rule CMS-0057-F” Fact Sheet
URL: https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-prior-authorization-final-rule-cms-0057-f
Date / Data period: 2024
Finding: CMS fact sheet summarizes the final rule’s goals around interoperability, prior authorization, transparency, and burden reduction.
Role in argument: Supports the same concrete example of administrative modernization and can be used for accessible summary language.
Caveats / limits: This is a fact sheet. It summarizes the rule but does not demonstrate implementation outcomes.
Source: Federal Register, “Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Advancing Interoperability and Improving Prior Authorization Processes”
URL: https://www.federalregister.gov/documents/2024/02/08/2024-00895/medicare-and-medicaid-programs-patient-protection-and-affordable-care-act-advancing-interoperability
Date / Data period: Published February 8, 2024
Finding: The Federal Register publishes the formal rule on advancing interoperability and improving prior authorization processes.
Role in argument: Provides the authoritative regulatory source for the CMS interoperability and prior-authorization reform.
Caveats / limits: Regulatory text establishes policy requirements but does not prove real-world effectiveness.
Source: JAMA Network Open, “Use of Ambient AI Scribes to Reduce Administrative Burden and Burnout”
URL: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2839542
Date / Data period: 2025
Finding: A 2025 JAMA Network Open quality-improvement study examined ambient AI scribes across multiple health systems and whether AI-generated clinical documentation could reduce administrative burden, documentation time, and clinician burnout.
Role in argument: Supports the possibility that technology may reduce the amount of human expertise consumed by administrative work.
Caveats / limits: This source supports potential administrative support, not replacement of clinicians. Implementation, accuracy, safety, governance, workflow integration, and unintended incentives remain important.
Source: NEJM AI, “Ambient AI Scribes in Clinical Practice: A Randomized Trial”
URL: https://ai.nejm.org/doi/abs/10.1056/AIoa2501000
Date / Data period: 2025
Finding: A 2025 NEJM AI randomized trial examined ambient AI scribes in clinical practice. Ambient scribes record patient encounters, generate draft clinical notes, and may reduce documentation workload.
Role in argument: Provides experimental evidence for AI-enabled administrative support in clinical documentation.
Caveats / limits: The source supports a narrow administrative-support use case. It does not imply AI can replace healthcare workers or solve systemic constraints by itself.
Source: JAMA Health Forum, “Implications of Artificial Intelligence–Powered Ambient Scribes”
URL: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2843726
Date / Data period: TBD
Finding: JAMA Health Forum cautions that AI documentation tools require governance. Potential risks include coding changes, increased spending, and inappropriate optimization around billing rather than care.
Role in argument: Provides a necessary caution against treating AI documentation tools as uncomplicated fixes.
Caveats / limits: This source is used for governance caution and implementation risk, not as direct evidence of effectiveness.
Synthesis
The evidence supports reducing friction as a near-term improvement pathway. Administrative complexity absorbs resources, prior authorization can delay needed care, and interoperability reforms show that system redesign is possible. AI documentation tools may help reduce documentation burden and redirect human time toward care, but they require governance and cannot substitute for clinicians. The strongest claim is that existing medicine can work better when fewer resources are consumed by avoidable friction.
5.4 — Extend Human Capacity
Core Claim
Healthcare remains fundamentally constrained by people. The goal is not to replace healthcare workers, but to help existing workers care for more people more effectively through team-based care, better workflows, community-based support, telehealth, AI-supported administration, and appropriate task distribution.
Evidence
Source: American Journal of Preventive Medicine, “Team-based care and improved blood pressure control: a Community Guide systematic review”
URL: https://pubmed.ncbi.nlm.nih.gov/24933494/
Date / Data period: Published July 2014; evidence base includes an earlier systematic review covering January 1980–July 2003 and a Community Guide update covering January 2003–May 2012
Finding: Proia, Thota, Njie, Finnie, Hopkins, Mukhtar, Pronk, Zeigler, Kottke, Rask, Lackland, Brooks, Braun, Cooksey, and the Community Preventive Services Task Force reviewed evidence on team-based care for blood-pressure control. The Community Guide update included 52 studies. Team-based care improved the proportion of patients with controlled blood pressure by a median of 12 percentage points, reduced systolic blood pressure by a median of 5.4 mmHg, and reduced diastolic blood pressure by a median of 1.8 mmHg. The authors concluded that team-based care improved blood-pressure outcomes, especially when pharmacists and nurses were part of the team.
Role in argument: Supports the claim that primary care does not have to mean one overburdened physician working alone. Team-based care can improve chronic-disease management and blood-pressure control by distributing care across pharmacists, nurses, primary-care providers, and other team members.
Caveats / limits: This is a systematic review of heterogeneous interventions across different settings and team structures. The “especially when pharmacists and nurses were part of the team” finding is directly supported by the source, but it should not be overread as proving that every team configuration works equally well or that team-based care is easy to implement. The authors note that implementation requires health-system-level organizational change.
DOI: 10.1016/j.amepre.2014.03.004
Source: Circulation: Cardiovascular Quality and Outcomes, “Integrating Community Health Workers into Community-Based Primary Care Practice Settings to Improve Blood Pressure Control Among South Asian Immigrants in New York City: Results from a Randomized Control Trial”
URL: https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009321
Date / Data period: Published March 2023; trial conducted in New York City community-based primary care practices between 2017 and 2019
Finding: Islam, Wyatt, Ali, Zanowiak, Mohaimin, Goldfeld, Lopez, Kumar, Beane, Thorpe, and Trinh-Shevrin evaluated Project IMPACT, an intervention integrating community health workers into community-based primary care practices serving South Asian patients with uncontrolled hypertension. The randomized controlled trial enrolled 303 South Asian adults with diagnosed hypertension and uncontrolled blood pressure across 14 clinic sites. Treatment participants received four additional group education sessions and individualized CHW-led health coaching over six months. At six-month follow-up, 68.2% of treatment participants had controlled blood pressure, compared with 41.6% of control participants. In adjusted analysis, treatment participants had 3.7 times the odds of achieving blood-pressure control compared with the control group.
Role in argument: Supports the claim that community health workers can improve hypertension outcomes when integrated into primary-care settings, especially through health coaching, culturally connected support, education, navigation, self-management support, and ongoing follow-up.
Caveats / limits: This is a randomized controlled trial in one population and setting: South Asian immigrants receiving care in community-based primary care practices in New York City. It supports the value of CHW-integrated care for hypertension control, but should not be generalized as proof that all CHW programs work equally well across all populations or health systems.
DOI: 10.1161/CIRCOUTCOMES.122.009321
Source: National Academy of Medicine, “Implementing Optimal Team-Based Care to Reduce Clinician Burnout”
URL: https://nam.edu/perspectives/implementing-optimal-team-based-care-to-reduce-clinician-burnout/
Date / Data period: TBD
Finding: National Academy of Medicine describes team-based care as a response to increasing complexity and clinician burnout.
Role in argument: Supports team-based care as a systems response to complexity, not simply a staffing workaround.
Caveats / limits: This source is strongest for framing and implementation perspective; it is not the primary outcomes evidence for blood-pressure improvement.
Source: “Task Sharing With Community Health Workers for Hypertension Control”
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11556888/
Date / Data period: TBD
Finding: Research on task-sharing with community health workers finds growing evidence that CHWs can improve hypertension control, including in high-income countries.
Role in argument: Supports community health workers as a way to extend human capacity through trust, communication, navigation, continuity, and ongoing support.
Caveats / limits: CHW programs depend on training, supervision, integration into care teams, sustainable funding, and community trust.
Source: Circulation: Cardiovascular Quality and Outcomes
URL: https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009321
Date / Data period: TBD
Finding: American Heart Association research finds CHW interventions improve hypertension outcomes through support with medication adherence, appointments, navigation, and ongoing management.
Role in argument: Reinforces the claim that health systems need more than clinical expertise; they also need navigation, continuity, communication, and support.
Caveats / limits: The current section does not provide the full article title, authors, or date. Final publication should complete the source trail if this remains load-bearing.
Source: Systematic Review, “Telemental Health in Rural Areas”
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10079469/
Date / Data period: TBD
Finding: A systematic review of telemental health in rural areas found telehealth services can improve symptoms of mental disorders among rural residents.
Role in argument: Supports telehealth as a capacity extender, especially where geography limits access.
Caveats / limits: Telehealth is not a replacement for clinicians, facilities, broadband access, trust, physical examination, or procedural care.
Source: National Rural Health Association, “Impact of Telehealth Policy on Rural Health Access”
URL: https://www.ruralhealth.us/nationalruralhealth/media/documents/nrha-impact-of-telehealth-policy-on-rural-health-access-2024.pdf
Date / Data period: 2024
Finding: National Rural Health Association identifies telehealth as a tool that can help connect rural providers with specialists, reduce geographic barriers, and support access.
Role in argument: Supports telehealth as a rural access and specialist-connection tool.
Caveats / limits: This is an association policy document. It supports the access argument but should be paired with empirical evidence when making outcome claims.
Source: Brown University, “Telemedicine Mental Health Access Study”
URL: https://www.brown.edu/news/2026-03-05/telemedicine-mental-health
Date / Data period: 2026
Finding: A 2026 Brown University study found telemedicine growth has not substantially improved mental-health access in some rural and underserved areas.
Role in argument: Provides a counterpoint showing that telehealth alone does not solve access problems.
Caveats / limits: This source cautions against overclaiming; its applicability depends on study design, geography, population, and mental-health access measures.
Source: “Nurse Practitioners and Physician Assistants in Primary Care”
URL: https://www.sciencedirect.com/science/article/abs/pii/S0011502916000146
Date / Data period: TBD
Finding: Research supports nurse practitioners and physician assistants as important parts of expanded primary-care teams. They can improve access and capacity when integrated into effective systems.
Role in argument: Supports the claim that healthcare capacity grows when teams are designed effectively and different professionals contribute appropriately.
Caveats / limits: Avoid entering scope-of-practice debates in this section. The source should be used for the broader capacity and team-design point, not as a full adjudication of role boundaries.
Synthesis
The evidence supports extending human capacity through better system design. Team-based care improves blood-pressure control when care is distributed across primary-care providers, pharmacists, nurses, and other team members. Community health workers can improve hypertension outcomes when integrated into primary-care settings, especially through culturally connected coaching, education, navigation, self-management support, and follow-up. Telehealth, nurse practitioners, physician assistants, and AI-supported administration also represent capacity-extending tools, but the strongest claim is not that technology or task-shifting replaces clinicians. It is that healthcare capacity grows when human work is better supported, better distributed, and less consumed by unnecessary friction.
5.5 — End With Realism
Core Claim
Near-term improvement is possible, but immediate perfection is not. Healthcare contains real constraints: workforce pipelines, infrastructure, difficult diseases, implementation challenges, trust, and resource limits.
Evidence
Source: AAMC, “New AAMC Report Shows Continuing Projected Physician Shortage”
URL: https://www.aamc.org/news/press-releases/new-aamc-report-shows-continuing-projected-physician-shortage
Date / Data period: Projection through 2036
Finding: AAMC projects physician shortages of up to 86,000 by 2036.
Role in argument: Prevents unrealistic conclusions by showing that workforce capacity cannot be fixed instantly.
Caveats / limits: Workforce projections are uncertain and depend on assumptions about population health, retirement, training pipelines, productivity, care models, and policy changes.
Source: HRSA, “State of the Health Workforce Report 2024”
URL: https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/state-of-the-health-workforce-report-2024.pdf
Date / Data period: 2024 report; projections through 2037
Finding: HRSA projects ongoing workforce shortages, especially in nonmetropolitan areas.
Role in argument: Reinforces that capacity problems vary by geography and require medium- and long-term planning.
Caveats / limits: Projections depend on supply-and-demand assumptions and may change with policy, training, migration, productivity, telehealth, and technology.
Source: March of Dimes, “Maternity Care Deserts Report”
URL: https://www.marchofdimes.org/maternity-care-deserts-report
Date / Data period: TBD
Finding: March of Dimes reports that more than one-third of U.S. counties are maternity-care deserts.
Role in argument: Provides a concrete example of a care-access constraint that cannot be solved merely by knowing what good maternity care requires.
Caveats / limits: County-level maternity-care desert designation does not capture all individual access experiences. Distance, transportation, insurance, risk level, hospital closures, workforce distribution, and social conditions all matter.
Synthesis
The evidence supports realism. Some improvements can happen relatively quickly, especially administrative simplification, better navigation, hypertension monitoring, screening outreach, vaccination outreach, team-based care, and documentation support. But deeper improvements require workforce training, infrastructure, rural-care capacity, public-health rebuilding, trust, and broader social supports. The correct claim is not that healthcare can be fixed immediately. It is that some suffering can be reduced much faster than people assume because many effective tools already exist.
Timeline Framework
1–3 years: Potential faster improvements include administrative simplification, electronic prior authorization, better scheduling and navigation, hypertension monitoring, screening outreach, vaccination outreach, AI documentation support, and CHW expansion where infrastructure exists.
3–7 years: Medium-term improvements include expanded team-based care, stronger primary-care systems, integrated behavioral health, expanded diabetes prevention, broader telehealth integration, and public-health data improvements.
Longer-term / Section 6: Deeper capacity-building includes physician workforce expansion, nursing workforce rebuilding, rural healthcare infrastructure, major public-health rebuilding, and social determinants of health.
Section-Level Caveats
This section does not argue that healthcare can be fixed immediately.
It does not argue that technology eliminates scarcity.
It does not argue that AI replaces clinicians.
It does not argue that prevention eliminates treatment needs.
It does not argue that all barriers are administrative.
The section’s core claim is narrower: many meaningful improvements are possible because humanity already possesses many of the required capabilities, and the challenge is deploying them.
Near-term improvements still require implementation capacity, trust, funding, workforce support, technical reliability, governance, and institutional cooperation.
AI documentation and administrative tools should be framed as support systems, not substitutes for clinicians or trusted human care.
Telehealth should be framed as a capacity extender, not a universal replacement for in-person care.
Prevention should be framed as reducing future suffering, not eliminating illness or shifting responsibility entirely to individuals.
Administrative simplification should be framed as reducing unnecessary friction, not eliminating all administration.
Workforce shortages, rural healthcare infrastructure, public-health rebuilding, and social determinants of health require longer-term work.
Open Questions / Research Gaps
What are the strongest exact sources for essential medicines as a near-term delivery opportunity?
What specific maternal-care interventions should be included under “expand access to what already works”?
What are the best sources for integrated behavioral healthcare as a 3–7 year improvement pathway?
What source should be used for exact childhood vaccination coverage percentages rather than the broad CDC MMWR page?
What exact annual SAMHSA NSDUH report should be used for mental-health treatment gaps?
Is the ScienceDirect source on nurse practitioners and physician assistants sufficient, or should a more accessible source be used?
What evidence best distinguishes administrative simplification that actually reduces burden from reforms that merely digitize existing complexity?
What implementation examples best show healthcare improvements occurring within one to three years versus three to seven years?
Which near-term improvements are most credible for a U.S.-first healthcare floor, and which require more local or system-specific conditions?
Evidence Status
Supported with caveats.
The section’s central claim is well supported: many meaningful healthcare improvements could occur relatively quickly because they depend on deploying existing capabilities more reliably rather than inventing entirely new science. Hypertension control, diabetes management, cancer screening, vaccination, mental-health access, chronic-disease prevention, blood-pressure monitoring, diabetes prevention, administrative simplification, prior-authorization reform, interoperability, AI documentation support, team-based care, community health workers, telehealth, and expanded primary-care teams all support this near-term improvement thesis.
The caveats are implementation and scope. These improvements require systems capable of funding, staffing, coordinating, governing, and sustaining them. They reduce suffering; they do not solve healthcare immediately. Section 6 should address the harder, slower work of rebuilding capacity, expanding infrastructure, creating durable systems, and addressing deeper material conditions.
Timeline Framework
1–3 Years
Potential faster improvements:
administrative simplification,
electronic prior authorization,
better scheduling/navigation,
hypertension monitoring,
screening outreach,
vaccination outreach,
AI documentation support,
CHW expansion where infrastructure exists.
3–7 Years
Medium-term improvements:
expanded team-based care,
stronger primary care systems,
integrated behavioral health,
expanded diabetes prevention,
broader telehealth integration,
public-health data improvements.
Longer-Term
Requires deeper capacity building:
physician workforce expansion,
nursing workforce rebuilding,
rural healthcare infrastructure,
major public-health rebuilding,
social determinants of health.

